Literature DB >> 35309958

Delayed post-pneumonectomy empyema necessitans caused by Aspergillus flavus: An unusual report.

Atousa Hakamifard1, Babak Gharedaghi2, Payam Tabarsi3, Shervin Shokouhi1,4, Halimeh Negahban1, Somayeh Sharifynia3, Atosa Dorudinia5.   

Abstract

Post-pneumonectomy empyema (PPE), with or without bronchopleural fistula, is a challenging and serious entity with significant mortality and morbidity. PPE is usually caused by bacteria such as staphylococci, streptococci and also gram-negative rods. Among fungal pathogens, Aspergillus species is a very rare cause of this entity. Herein, we describe an unusual case of delayed post-pneumonectomy empyema necessitans caused by Aspergillus flavus in a 65-year-old man with favourable clinical outcome by combined surgical and antifungal therapy.
© 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  Aspergillus; abscess; empyema; fungal infections; lung cancer; pneumonectomy

Year:  2022        PMID: 35309958      PMCID: PMC8907913          DOI: 10.1002/rcr2.930

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


INTRODUCTION

Post‐pneumonectomy empyema (PPE), with or without bronchopleural fistula (BPF), is a challenging, serious and uncommon complication responsible for significant mortality and morbidity. The incidence of PPE with or without BPF is reported between 0.8% and 15%. , It can occur at any time after pneumonectomy, including years later. The risk factors consist of general factors including diabetes, sepsis, corticosteroid therapy and local factors including pre‐existent empyema, right pneumonectomy and preoperative local radiotherapy. , Pleural empyema is mainly caused by bacteria. Early PPE is mostly associated with poly‐microbial cultures, including gram‐negative bacteria. By contrast, delayed PPE is mostly mono‐microbial with gram‐positive bacteria. PPE caused by Aspergillus species is very rare and mainly affect the immunocompromised hosts. Herein, we report a case of delayed post‐pneumonectomy empyema necessitans caused by Aspergillus flavus with favourable clinical outcome by combined surgical and antifungal therapy.

CASE REPORT

In September 2021, a 65‐year‐old man presented to the emergency department with a 20‐day history of cough and skin erythema with purulent and foul‐smelling discharge from the previous thoracotomy site. In April 2019, he underwent right pneumonectomy for lung squamous cell carcinoma in combination with chemotherapy. At admission, the patient was haemodynamically stable and afebrile. Physical examination was unremarkable except for erythema of the right chest wall with cutaneous fistula and purulent discharge. The complete blood count showed a leucocyte count of 11,800 cells/μl, a haemoglobin level of 10 g/dl and a platelet count of 336,000 platelets/μl. Renal function tests and liver enzymes were within normal ranges. The pleural fluid analysis was as following: white blood cells: many, Polymorphonuclear leukocytes (PMN): 99%, glucose: 13 mg/dl, protein: 4 g/dl, lactate dehydrogenase: >15,000 IU/L. Empiric treatment with piperacillin‐tazobactam (4.5 g every 6 h) and vancomycin (1 g every 12 h) was initiated. According to the right empyema necessitans, the patient underwent drainage of the pleural space immediately. In the operating room, at the site of the previous thoracotomy incision, in the anterior fifth axillary space, incision was made, and about 500 cc of thick and foul‐smelling purulent discharge was drained from the area between the skin and the thoracic wall. Then, by entering the right hemithorax cavity, about 2 L of thick pus came out and chest tube was inserted. The purulent discharge and chest wall tissue resection were evaluated for histopathology, smear and culture (Figures 1, 2, 3).
FIGURE 1

Chest x‐ray after chest tube insertion

FIGURE 2

Erythema of the right chest wall with cutaneous fistula and purulent discharge

FIGURE 3

Copious purulent discharge was drained in the operating room

Chest x‐ray after chest tube insertion Erythema of the right chest wall with cutaneous fistula and purulent discharge Copious purulent discharge was drained in the operating room Gross pathological examination showed the specimen consisted of one membranous tan‐yellow elastic tissue fragment measuring 10 × 5 cm in area and 0.3 cm in thickness. Histopathological examination revealed necrohyalinization with invasion of hyaline fungal hyphae in favour of Aspergillus species (Figure 4). The extract of tissue DNA sequencing established the diagnosis of post‐pneumonectomy Aspergillus flavus empyema necessitans. Hence, piperacillin‐tazobactam and vancomycin were discontinued and intravenous voriconazole 6 mg/kg every 12 h for day 1 and 4 mg/kg every 12 h for the following was initiated. Seven days later, Eloesser flap, an open window thoracostomy procedure, was performed successfully which allowed passive drainage of the purulent discharge. This procedure allowed sufficient access to the pleural space, effective packing, serial dressing changes and also debridement, until the cavity became sterile (Figure 5). Due to high inflammation, the bronchial fistula was not manipulated and toilet bronchoscopy was performed at the end. After 10 days, the patient was discharged with favourable clinical outcome and the therapy switched to oral voriconazole.
FIGURE 4

Histopathological examination revealed necrohyalinization with invasion of hyaline septated fungal hyphae (haematoxylin and eosin stain 10 × 20 magnification)

FIGURE 5

Eloesser flap procedure was performed, which allowed passive drainage of the purulent discharge

Histopathological examination revealed necrohyalinization with invasion of hyaline septated fungal hyphae (haematoxylin and eosin stain 10 × 20 magnification) Eloesser flap procedure was performed, which allowed passive drainage of the purulent discharge

DISCUSSION

PPE is classified into three types including PPE associated with BPF, PPE without BPF or PPE of haematogenous origin. PPE associated with BPF is the most common and serious type that is usually caused by bacteria such as staphylococci, streptococci and also gram‐negative rods. Among fungal aetiologies, Candida spp. have been more frequently reported than Aspergillus species and the latter is a very rare cause of this entity. The incidence of BPF after pneumonectomy is greater than that after lobectomy. Some authors use a 3‐week period to distinguish the acute phase from the chronic phase PPE. When infected pleural fluid dissects the parietal pleura and invades the subpleural tissues, empyema necessitans occurs. Invasion into the surrounding soft tissue of the chest wall leads to subcutaneous abscess formation, which can extend to the trachea, oesophagus and diaphragm. In severe cases, discharge may be externalized. The most likely pathogen for empyema necessitans is Mycobacterium tuberculosis, and less commonly are Nocardia, Actinomyces and Aspergillus species. , There are some reports on the spontaneous empyema necessitans caused by Aspergillus species and, on the other hand, there are very few cases of post‐pneumonectomy Aspergillus pleural empyema necessitans. Lee et al. reported a 58‐year‐old woman who presented with painful skin rash on the right thorax and three fistulas communicating with the pleural space. Pleural culture showed Aspergillus fumigatus and also chest wall biopsy revealed numerous fungal hyphae. The diagnosis of spontaneous empyema necessitans was made and the patient treated with necrotic tissue debridement and antifungal agents. Chen et al. reported a 60‐year‐old woman who presented with fever, chest wall pain and mild dyspnoea with an abscess formation in area of low density in the chest wall on CT scan of the chest. The resected specimens revealed abundant hyphae of Aspergillus species. The patient was treated with itraconazole and surgical debridement. Bonatti et al. reported four cases of post‐pneumonectomy Aspergillus pleural empyema. Two patients had lung cancer, one had Hodgkin's disease and one of the patient acquired aspergillosis by thoracic trauma. The risk factors reported for these patients were poly‐chemotherapy, cachexia, locally recurrent, pleural carcinomas and radiation. In all of the four patients, empyema was treated with surgery in combination of voriconazole and caspofungin. Lampo et al. described a case of an immunocompetent 54‐year‐old woman, who developed Aspergillus empyema invading the thoracic wall and subcutaneous tissues after completion pneumonectomy for aspergilloma. Local and systemic amphotericin therapy for 8 weeks was continued but according to the persistent infection, an open window thoracostomy was performed and the patient was on itraconazole for 6 months with favourable outcome. Our patient had a history of right pneumonectomy for lung cancer 2 years before his current admission. He was hospitalized because of cough and purulent discharge from the right side of chest wall and the diagnosis of post‐pneumonectomy Aspergillus flavus empyema necessitans was made. Another point about our patient is that the last chemotherapy for lung cancer was 2 years ago. The patient was not neutropenic at the time of admission and also had no evidence of other immunodeficiency status. Management in the late phase of PPE includes sterilization of the pleural space, closure of the BPF and chest wall closure. This closure can only be performed when the pleural cavity has been cleared of Aspergillus. The presented case underwent drainage of the pleural space initially and treated with voriconazole and surgical debridement, and then Eloesser flap procedure was performed with favourable clinical outcome. In conclusion, PPE with BPF can be caused by Aspergillus species in some patients. A surgical approach combined with antifungal therapy can enable successful treatment of this serious complication.

CONFLICT OF INTEREST

None declared.

ETHICS STATEMENT

The authors declare that appropriate written informed consent was obtained for the publication of this manuscript and accompanying images.
  13 in total

1.  Management of postpneumonectomy Aspergillus empyema extending into the thoracic wall: a plea for radical surgery and caution when using liposomal amphotericin B.

Authors:  N Lampo; A Spiliopoulos; M Licker; J-M Tschopp
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

2.  Empyema necessitatis: unique presentation in a coccidioidomycosis case.

Authors:  Adrian Rendon; Ruth A Rendon; Otto Bauerle
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

3.  Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence.

Authors:  C Deschamps; A Bernard; F C Nichols; M S Allen; D L Miller; V F Trastek; G D Jenkins; P C Pairolero
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

Review 4.  Postpneumonectomy empyema: risk factors, prevention, diagnosis, and management.

Authors:  Harmouchi Hicham; Issoufou Ibrahim; Sani Rabiou; Lakranbi Marouane; Ouadnouni Yassine; Smahi Mohamed
Journal:  Asian Cardiovasc Thorac Ann       Date:  2019-12-22

5.  Prediction of early bronchopleural fistula after pneumonectomy: a multivariate analysis.

Authors:  F J Algar; A Alvarez; J L Aranda; A Salvatierra; C Baamonde; F J López-Pujol
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

6.  Late-onset post-pneumonectomy empyema.

Authors:  W F Kerr
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

7.  Nocardia nova causing empyema necessitatis afterlung re-transplantation: a case report.

Authors:  Cecília Bittencourt Severo; Letícia Beatriz Matter; Flávio de Mattos Oliveira; Agueda Palmira Castagna Vargas; Sadi Marcelo Schio; José de Jesus Peixoto Camargo; Bruno Hochhegger; Luiz Carlos Severo
Journal:  Rev Soc Bras Med Trop       Date:  2016 Jul-Aug       Impact factor: 1.581

8.  Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.

Authors:  H Bonatti; C Lass-Floerl; K Angerer; N Singh; M Lechner; I Stelzmueller; R Singh; T Schmid; C Geltner
Journal:  Mycoses       Date:  2009-05-29       Impact factor: 4.377

9.  Empyema necessitans caused by Mycobacterium tuberculosis in an immunocompetent patient.

Authors:  David J Magness
Journal:  WMJ       Date:  2013-06

Review 10.  Bronchopleural fistulas associated with lung cancer operations. Univariate and multivariate analysis of risk factors, management, and outcome.

Authors:  H Asamura; T Naruke; R Tsuchiya; T Goya; H Kondo; K Suemasu
Journal:  J Thorac Cardiovasc Surg       Date:  1992-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.